Idiopathic Membranous Nephropathy: An Autoimmune Disease

Seminars in Nephrology

Volumn 31, Issue 4, 2011, Pages 333-340

  Makker, Sudesh P ^a   Tramontano, Alfonso ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; Heymann models; IgG4; Membranous nephropathy; PLA2 receptor; Podocyte autoantigens

Indexed keywords

ALDEHYDE REDUCTASE; ALPHA ENOLASE; AUTOANTIBODY; AUTOANTIGEN; CD20 ANTIGEN; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 13; MANGANESE SUPEROXIDE DISMUTASE; MEGALIN; PHOSPHOLIPASE A2 RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN SERINE THREONINE KINASE; PROTEINASE; SECRETIN; UBIQUITIN; VIMENTIN;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNE DISEASE; DISEASE COURSE; GLOMERULUS; HELPER CELL; HEYMANN NEPHRITIS; HUMAN; IDIOPATHIC DISEASE; IMMUNE COMPLEX DEPOSITION; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; KIDNEY BIOPSY; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROSIS; NEPHROTIC SYNDROME; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOGLOBULIN G; PODOCYTES; RECEPTORS, PHOSPHOLIPASE A2;

EID: 79961233111     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2011.06.004     Document Type: Article

References (53)

1. Makker S.P. Treatment of membranous nephropathy in children. Semin Nephrol 2003, 23:379-385.
2. Polanco N., Gutierrez E., Covarsi A., Ariza F., Carreno A., Vigil A., et al. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol 2010, 21:697-704.
3. Glassock R.J. Idiopathic membranous nephropathy: getting better by itself. J Am Soc Nephrol 2010, 21:551-552.
4. Glassock R.J. Diagnosis and natural course of membranous nephropathy. Semin Nephrol 2003, 23:324-332.
5. Glassock R.J. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis 2010, 56:157-167.
6. Heymann W., Hackel D., Harwood J., Wilson S., Hunter J. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med 1959, 100:660-664.
7. Glassock R.J., Edgington T.S., Watson J.I., Dixon F.J. Autologous immune complex nephritis induced with renal tubular antigen. II. The pathogenetic mechanism. J Exp Med 1968, 127:573-588.
8. Makker S., Singh A. Biochemical analysis of nephritogenic rat kidney tubular membrane fraction (Fx1A) [abstract]. Fed Proc 1982, 41:1159.
9. Kerjaschki D., Farquhar M. Identification of a membrane glycoprotein from kidney brush border as the pathogenic antigen of Heymann's nephritis [abstract]. Fed Proc 1982, 41:692.
10. Kerjaschki D., Farquhar M.G. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A 1982, 79:5557-5581.
11. Makker S., Singh A. Characterization of the antigen (gp600) of Heymann nephritis. Lab Invest 1984, 50:287-293.
12. Huang J., Makker S. Role of receptor-associated 39-45kDa protein in active Heymann nephritis. Kidney Int 1995, 47:432-441.
13. Oleinikov A.V., Feliz B.J., Makker S.P. A small N-terminal 60-kD fragment of gp600 (megalin), the major autoantigen of active Heymann nephritis, can induce a full-blown disease. J Am Soc Nephrol 2000, 11:57-64.
14. Feenstra K., van den Lee R., Greben H.A., Arends A., Hoedemaeker P.J. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. I. The natural history: a histologic and immunohistologic study at the light microscopic and the ultrastructural level. Lab Invest 1975, 32:235-242.
15. Van Damme B.J., Fleuren G.J., Bakker W.W., Vernier R.L., Hoedemaeker P.J. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis. Lab Invest 1978, 38:502-510.
16. Couser W.G., Steinmuller D.R., Stilmant M.M., Salant D.J., Lowenstein L.M. Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest 1978, 62:1275-1287.
17. Makker S.P., Tramontano A. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis-implications for the pathogenesis of idiopathic human membranous glomerulonephritis. J Pathol 2006, 210:282-287.
18. Hunter J.L., Hackel D.B., Heymann W. Nephrotic syndrome in rats produced by sensitization to rat kidney proteins: immunologic studies. J Immunol 1960, 85:319-327.
19. Heymann W., Hunter J.L., Hackel D.B. Experimental auto-immune nephrosis in rats: III. J Immunol 1962, 88:135-141.
20. Alousi M.A., Post R.S., Heymann W., Cuppage F.E. Immunohistological and electron microscopic studies of experimental autoimmune nephrosis in rats; comparison with human renal biopsies. Fed Proc 1967, 26:743.
21. Makker S.P., Widstrom R., Huang J. Membranous nephropathy, interstitial nephritis, and Fanconi syndrome-glomerular antigen. Pediatr Nephrol 1996, 10:7-13.
22. Okuda R., Kaplan M.H., Cuppage F.E., Heymann W. Deposition of autologous gamma globulin in kidneys of rats with nephrotic renal disease of various etiologies. J Lab Clin Med 1965, 66:204-215.
23. Germuth F.G., Pace M.G., Tippett J.C. Comparative histologic and immunologic studies in rabbits of induced hypersensitivity of the serum sickness type. II. The effect of sensitization to homologous and cross-reactive antigens on the rate of antigen elimination and the development of allergic lesions. J Exp Med 1955, 101:135-150.
24. Dixon F.J., Feldman J.D., Vazquez J.J. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med 1961, 113:899-920.
25. Kerjaschki D., Farquhar M.G. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J Exp Med 1983, 157:667-686.
26. Makker S.P., Moorthy B. In situ immune complex formation in isolated perfused kidney using homologous antibody. Lab Invest 1981, 44:1-5.
27. Lundgren S., Carling T., Hjalm G., Juhlin C., Rastad J., Pihlgren U., et al. Tissue distribution of human gp330/megalin, a putative Ca(2+)-sensing protein. J Histochem Cytochem 1997, 45:383-392.
28. Appel D., Kershaw D.B., Smeets B., Yuan G., Fuss A., Frye B., et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009, 20:333-343.
29. Ronconi E., Sagrinati C., Angelotti M.L., Lazzeri E., Mazzinghi B., Ballerini L., et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 2009, 20:322-332.
30. Debiec H., Guigonis V., Mougenot B., Decobert F., Haymann J.P., Bensman A., et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002, 346:2053-2060.
31. Ronco P., Debiec H. Molecular dissection of target antigens and nephritogenic antibodies in membranous nephropathy: towards epitope-driven therapies. J Am Soc Nephrol 2006, 17:1772-1774.
32. Makker S.P. Analysis of glomeruli-eluted Gp330 autoantibodies and of Gp330 antigen of Heymann nephritis. J Immunol 1993, 151:6500-6508.
33. Beck L.H., Bonegio R.G., Lambeau G., Beck D.M., Powell D.W., Cummins T.D., et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009, 361:11-21.
34. Prunotto M., Carnevali M.L., Candiano G., Murtas C., Bruschi M., Corradini E., et al. Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J Am Soc Nephrol 2010, 21:507-519.
35. Saleem M.A., O'Hare M.J., Reiser J., Coward R.J., Inward C.D., Farren T., et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002, 13:630-638.
36. Janeway C.A., T P., Walport M., Shlomchik M.J. Immunobiology 2005, Garland Science Taylor and Francis Group, New York. 6th ed.
37. Wakui H., Imai H., Komatsuda A., Miura A.B. Circulating antibodies against alpha-enolase in patients with primary membranous nephropathy (MN). Clin Exp Immunol 1999, 118:445-450.
38. Ronco P., Debiec H. Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy. J Am Soc Nephrol 2010, 21:564-569.
39. Stahl R., Hoxha E., Fechner K. PLA2R autoantibodies and recurrent membranous nephropathy after transplantation. N Engl J Med 2010, 363:496-498.
40. Tramontano A., Knight T., Vizzuso D., Makker S.P. Nested N-terminal megalin fragments induce high-titer autoantibody and attenuated Heymann nephritis. J Am Soc Nephrol 2006, 17:1979-1985.
41. Ruggenenti P., Cravedi P., Sghirlanzoni M.C., Gagliardini E., Conti S., Gaspari F., et al. Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy. Clin J Am Soc Nephrol 2008, 3:1652-1659.
42. Shah P., Tramontano A., Makker S.P. Intramolecular epitope spreading in Heymann nephritis. J Am Soc Nephrol 2007, 18:3060-3066.
43. Kanalas J.J., Makker S.P. Identification of the rat Heymann nephritis autoantigen (GP330) as a receptor site for plasminogen. J Biol Chem 1991, 266:10825-10829.
44. Makker S. A novel autoantibody to plasminogen and its characterization in Heymann nephritis. Clin Immunol Immunopathol 1994, 72:105-113.
45. Klassen J., Sugisaki T., Milgrom F., McCluskey R.T. Studies on multiple renal lesions in Heymann nephritis. Lab Invest 1971, 25:577-585.
46. Bautz D.J., Preston G.A., Lionaki S., Hewins P., Wolberg A.S., Yang J.J., et al. Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis. J Am Soc Nephrol 2008, 19:2421-2429.
47. Makker S.P., Widstrom R., Huang J. Transcription and translation of gp600 and receptor-associated protein (RAP) in active Heymann nephritis. Am J Pathol 1995, 146:1481-1487.
48. Doi T., Mayumi M., Kanatsu K., Suehiro F., Hamashima Y. Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol 1984, 58:57-62.
49. Imai H., Hamai K., Komatsuda A., Ohtani H., Miura A.B. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int 1997, 51:270-276.
50. Aalberse R.C., Stapel S.O., Schuurman J., Rispens T. Immunoglobulin G4: an odd antibody. Clin Exp Allergy 2009, 39:469-477.
51. Kuroki A., Iyoda M., Shibata T., Sugisaki T. Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. Kidney Int 2005, 68:302-310.
52. van der Neut Kolfschoten M., Schuurman J., Losen M., Bleeker W.K., Martinez-Martinez P., Vermeulen E., et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007, 317:1554-1557.
53. Tramontano A., Makker S.P. Conformation and glycosylation of a megalin fragment correlate with nephritogenicity in Heymann nephritis. J Immunol 2004, 172:2367-2373.